Chemotherapy in elderly patients with advanced non-small cell lung cancer
Authors:
- Elisabeth QuoixEQElisabeth Quoix
- Virginie WesteelVWVirginie Westeel
- Gérard ZalcmanGZGérard Zalcman
- Bernard MilleronBMBernard Milleron
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 74 (3) , 364-368
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- IFCT 02-02 : la prise en charge du cancer bronchique chez les patients âgés de 70 ans et plus en FranceRevue des Maladies Respiratoires, 2010
- Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results DatabaseJournal of Clinical Oncology, 2007
- Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapyCancer, 2007
- International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiencyEuropean Journal of Cancer, 2007
- Elderly Patients Have Become the Leading Drug Consumers: It's High Time to Properly Evaluate New Drugs Within the Real Targeted PopulationJournal of Clinical Oncology, 2006
- Increasing underrepresentation of elderly patients with advanced colorectal or non‐small‐cell lung cancer in chemotherapy trialsInternal Medicine Journal, 2006
- EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancerEuropean Journal of Cancer, 2003
- Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?Journal of Clinical Oncology, 2003
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999